Skye Bioscience (SKYE) PT Lowered to $14 at Craig-Hallum
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SKYE Hot Sheet
Price: $1.14 --0%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 26 | New: 2
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 26 | New: 2
Join SI Premium – FREE
Craig-Hallum analyst Albert Lowe lowered the price target on Skye Bioscience (NASDAQ: SKYE) to $14.00 (from $18.00) while maintaining a Buy rating.
You May Also Be Interested In
- Joby Aviation Inc (JOBY) PT Lowered to $10 at Needham
- Xiaomi Corp (1810:HK) (XIACF) PT Lowered to HK$35 at Goldman Sachs
- Eagle Materials (EXP) PT Raised to $195 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
